Skip to main content

Table 3 CTC positivity and association with prognostic factors

From: Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

 

CTC1+

CTC2+

CTC3+

CTC4+

Age, y ≤65

1

2

2

0

 >65

4

6

9

1

p value

1.000

1.000

0.712

1.000

PSA <10 ng/mL

2

1

4

1

 10-20 ng/mL

2

5

4

0

 >20 ng/mL

1

2

2

0

p value

0.852

0.128

0.711

1.000

Gleason <8

3

7

5

1

 sum ≥ 8

2

1

6

0

p value

1.000

0.128

0.502

1.000

T Stage

 <T3

0

1

6

0

 ≥T3

5

7

5

1

p value

0.312

0.668

0.062

1.000

N Stage

 0

5

7

7

1

 1

0

1

4

-

p value

0.574

1.000

0.053

 

Secondary tumors

 Yes

3

6

9

0

 No

2

2

2

1

p value

0.621

1.000

0.484

0.231

  1. PSA prostate-specific antigen